{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:05:24Z","timestamp":1785168324833,"version":"3.55.0"},"reference-count":48,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003670","name":"National Evidence-based Healthcare Collaborating Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["HA21C0110"],"award-info":[{"award-number":["HA21C0110"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Growing evidence suggests that chronic hepatitis B (CHB) patients with high viremia are at a high risk of developing hepatocellular carcinoma (HCC) even with normal alanine transaminase (ALT) levels. This study aimed to evaluate the cost\u2010effectiveness of initiating antiviral therapy in patients in an indeterminate phase of CHB, defined as those who do not clearly fit into the established four phases categorised by serum HBV DNA and ALT levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cost\u2010utility analysis was conducted using a Markov model to compare the incremental cost\u2010effectiveness ratio (ICER) of initiating antiviral therapy at the indeterminate phase (\u2018treat\u2010Indet\u2019) versus delaying treatment until chronic hepatitis (\u2018untreated\u2010Indet\u2019). A hypothetical cohort of 10\u2009000 patients in the indeterminate phase (60% male, HBV DNA 4\u20138 log\n                      <jats:sub>10<\/jats:sub>\n                      IU\/mL, ALT &lt;\u200940\u2009IU\/L, 50% HBeAg\u2010positivity) was simulated over a 10\u2010year horizon. Input parameters were obtained from a Korean multicentre historical cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From a healthcare system perspective, the ICER of the treat\u2010Indet strategy was US$12050\/quality\u2010adjusted life\u2010year (QALY), indicating cost\u2010effectiveness under the local willingness\u2010to\u2010pay threshold of US$25000\/QALY. From a societal perspective, the ICER was less than 0, indicating lower costs. A U\u2010shaped association was identified between baseline HBV DNA levels and the ICER, as HBV DNA levels of 6\u20137 log\n                      <jats:sub>10<\/jats:sub>\n                      IU\/mL were associated with the lowest ICER (US$2018\/QALY), followed by 5\u20136 (US$7233\/QALY), 7\u20138 (US$19677\/QALY) and 4\u20135 log\n                      <jats:sub>10<\/jats:sub>\n                      IU\/mL (US$24570\/QALY), following the order of HCC risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Initiating antiviral therapy in high\u2010viremic indeterminate phase CHB patients with normal ALT levels was cost\u2010effective compared with delaying treatment until chronic hepatitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/liv.70238","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:28:44Z","timestamp":1753277324000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cost\u2010Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B"],"prefix":"10.1111","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-7635","authenticated-orcid":false,"given":"Suk\u2010Chan","family":"Jang","sequence":"first","affiliation":[{"name":"School of Pharmacy Sungkyunkwan University  Suwon Gyeonggi\u2010do Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-1765","authenticated-orcid":false,"given":"Won\u2010Mook","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Liver Center, Asan Medical Center University of Ulsan College of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-0822","authenticated-orcid":false,"given":"Gi\u2010Ae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Kyung Hee University School of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-8427","authenticated-orcid":false,"given":"Gwang Hyeon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital Seoul National University College of Medicine  Seongnam\u2010si Gyeonggi\u2010do Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Bin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Sinn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-8787","authenticated-orcid":false,"given":"Hye\u2010Lin","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy Sahmyook University  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1544-577X","authenticated-orcid":false,"given":"Young\u2010Suk","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Liver Center, Asan Medical Center University of Ulsan College of Medicine  Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2211764"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00386-7"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000518940"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.018"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28280"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.01.002"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13185"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.01.019"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15725"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154833"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330225"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/M24-0384"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.07.031"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(24)00562-2"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.12.007"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000459"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00431-X"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.02.032"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.10.008"},{"key":"e_1_2_12_22_1","unstructured":"Health Insurance Review & Assessment Service (HIRA) \u201cThe Pharmacoeconomic Evaluation Guideline (2021.1) \u201daccessed November 04 2024 https:\/\/www.hira.or.kr\/ebooksc\/ebook_630\/ebook_630_202103150917443810.pdf."},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3486-7"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000299"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix506"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321309"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.10.026"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33638"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305517"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001195"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.031"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17052"},{"key":"e_1_2_12_34_1","volume-title":"A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report","author":"National Academies of Sciences E, Medicine","year":"2017"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12064"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005376"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23785"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18278"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00297.x"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003896"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.24304\/kjcp.2018.28.1.57"},{"key":"e_1_2_12_42_1","unstructured":"Health Insurance Review & Assessment Service (HIRA) \u201cWeighted Average Durg Prices in the First Half of 2023 \u201daccessed January 23 2024 https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA030017000000&brdScnBltNo=4&brdBltNo=1632&pageIndex=1&pageIndex2=1#none."},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00162-6"},{"key":"e_1_2_12_44_1","volume-title":"Asian Collaborative Study on Cost\u2010Effectiveness in Healthcare Decision Making","author":"Ahn J.","year":"2012"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0322"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.1150"},{"key":"e_1_2_12_47_1","volume-title":"Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection","author":"Guidelines for the prevention","year":"2024"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100738"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00008-1"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:19:20Z","timestamp":1761070760000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.70238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1111\/liv.70238"],"URL":"https:\/\/doi.org\/10.1111\/liv.70238","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2024-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70238"}}